Insomnia
RecruitingStudy of tasimelteon compared to placebo for treating insomnia in children
- Disease:Insomnia
- Substances:Tasimelteon
Germany- Participants:0–17 years
- Substances:Tasimelteon
- Sponsor:Vanda Pharmaceuticals Inc.
Rare diseases
Investigational molecules
Locations
Basisweg 10, 1043 AP Amsterdam, The Netherlands
Clinical research in insomnia disorder with a focus on sleep outcomes, sleep maintenance, and symptom relief in pediatric and other affected populations.
Interest in measuring changes in nightly sleep patterns and patient-reported sleep experience across multiple active research sites.
Vanda Pharmaceuticals Netherlands B.V. runs clinical trials in conditions such as Insomnia, Major depression, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Germany
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.